OXLUMO

Serial Number 88576813
Registration 6290281
700

Registration Progress

Application Filed
Aug 13, 2019
Under Examination
Dec 10, 2019
Approved for Publication
Oct 15, 2019
Published for Opposition
Oct 15, 2019
Registered
Mar 9, 2021

Basic Information

Serial Number
88576813
Registration Number
6290281
Filing Date
August 13, 2019
Registration Date
March 9, 2021
Published for Opposition
October 15, 2019
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 9, 2021
Registration
Registered
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Timothy H. Hiebert

USPTO Deadlines

Next Deadline
608 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-03-09)
Due Date
March 09, 2027
Grace Period Ends
September 09, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description
Mar 9, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Feb 4, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 3, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 2, 2021 DOCK D ASSIGNED TO EXAMINER
Jan 24, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 24, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jan 5, 2021 EISU I TEAS STATEMENT OF USE RECEIVED
Jan 5, 2021 IUAF S USE AMENDMENT FILED
Dec 4, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 2, 2020 EX2G S SOU EXTENSION 2 GRANTED
Dec 2, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 2, 2020 EXT2 S SOU EXTENSION 2 FILED
Jun 2, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 29, 2020 EXT1 S SOU EXTENSION 1 FILED
May 29, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
May 29, 2020 EX1G S SOU EXTENSION 1 GRANTED
Dec 10, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 15, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2019 PUBO A PUBLISHED FOR OPPOSITION
Sep 25, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 10, 2019 DOCK D ASSIGNED TO EXAMINER
Sep 10, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 29, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 28, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 16, 2019 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of primary hyperoxaluria
First Use Anywhere: Dec 17, 2020
First Use in Commerce: Dec 17, 2020

Additional Information

Design Mark
The mark consists of the word "OXLUMO" and a design of three hexagonal shapes in different sizes, the smaller two of which are adjacent to each other, and the largest of which is shown in different shading surrounding the smallest hexagon and partly overlapping the mid-sized hexagon.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording "OXLUMO" has no meaning in a foreign language.

Classification

International Classes
005